• AAPL 171.95
  • TSLA 156.99
  • AMZN 183.345
  • MSFT 414.3044
  • INTC 36.27
  • EURUSD 1.0637
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. IMRX.NASDAQ

Immuneering Corp (IMRX NASDAQ) stock market data APIs

$2.07 0.16(8.4%) as of April 15, 2024

Immuneering Corp Financial Data Overview

1.915
2.07
-
2.08
1.89
1.89-14.29
61 202 K
29 283 K
455
-0.52
-0.894
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'IMRX',
Type: 'Common Stock',
Name: 'Immuneering Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG009QXJQS1',
ISIN: NULL,
CUSIP: NULL,
CIK: '1790340',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-07-30',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Immuneering Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 455
  • EBITDA -58 060 804
  • Earnings Per Share -1.88
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Immuneering Corp Earnings via APIs

  • Latest Release 2024-03-01
  • EPS/Forecast -0.47

Get Immuneering Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Immuneering Corp latest news via APIs

Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference

CAMBRIDGE, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop medicines for broad populations of cancer patients wi...
  • CALENDAR OF EVENTS
  • CONFERENCE
  • CONFERENCE CALLS/ WEBCASTS
  • IMM-1-104
  • IMM-6-415
  • IMMUNEERING CORPORATION
  • NASDAQ:IMRX
  • PIPER
  • PIPERSANDLER

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Immuneering Corporation (NASDAQ: IMRX) and Encourages Investors to Contact the Firm

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Immuneering Corporation (NASDAQ: IMRX) on behalf of the company’s investors. Since October 2021...
  • CLASS ACTION
  • KASKELA LAW
  • LAW & LEGAL ISSUES
Do you have any questions?
support@eodhistoricaldata.com